RETRACTED ARTICLE: Differences and Challenges in the Guides of America Central Versus North America in the Timely Diagnosis of Retinoblastoma
DOI:
https://doi.org/10.56172/oftalmica.v20i.22Keywords:
Retinoblastoma, Tumor, Therapeutic options, AHOPCAAbstract
Editor´'s note: the retraction ocurred since the authors sent the article to other journal that also published the work. The article was retracted from journal Oftalmica on 02.08.2022.
Retinoblastoma is a malignant tumor arising from the embryonic neural retina and is the most common intraocular tumor of childhood, occurring in approximately 1 in 14,000-18,000 live births. Current therapeutic options for retinoblastoma have improved its prognosis considerably in recent decades to the point of not only directing treatment to save the patient's life, but also aiming to save the eye and preserve vision.
Downloads
References
Chintagumpala M, Chevez-Barrios P, Paysse E, Plon S, Hurwitz R. Retinoblastoma: Review of Current Management. The Oncologist. 2007;12(10):1237-1246. https://doi.org/10.1634/theoncologist.12-10-1237 DOI: https://doi.org/10.1634/theoncologist.12-10-1237
Stefan D. Pediatric Hematology-Oncology in Countries with Limited Resources a Practical Manual. 1st ed. Boston, MA, USA: Springer-Verlag New York; 2016.
Rodriguez-Galindo C, Wilson M, Chantada G, Fu L, Qaddoumi I, Antoneli C et al. Retinoblastoma: One World, One Vision. PEDIATRICS. 2008;122(3):e763-e770. https://doi.org/10.1542/peds.2008-0518 DOI: https://doi.org/10.1542/peds.2008-0518
Barr R, Klussmann F, Baez F, Bonilla M, Moreno B, Navarrete M et al. Asociación de Hemato-Oncología Pediátrica de Centro América (AHOPCA): A model for sustainable development in pediatric oncology. Pediatric Blood & Cancer. 2013;61(2):345-354. https://doi.org/10.1002/pbc.24802 DOI: https://doi.org/10.1002/pbc.24802
Burnier Jr M, Zoroquiain P, Fernández A. Curso: Oftalmología Pediátrica: Retinoblastoma y Diagnóstico Diferencial [en línea] [Citado el 0 de febrero 2021]. Disponible en: https://www.campuspaao.org/course/view.php?id=246
Luna-Fineman, S., Barnoya, M., Bonilla, M., Fu, L., Baez, F., & Rodríguez-Galindo, C. (2011). Retinoblastoma in Central America: Report from the Central American Association of Pediatric Hematology Oncology (AHOPCA). Pediatric Blood & Cancer, 58(4), 545-550. doi:10.1002/pbc.23307 https://doi.org/10.1002/pbc.23307 DOI: https://doi.org/10.1002/pbc.23307
Luna-Fineman S, Chantada G, Alejos A, Amador G, Barnoya M, Castellanos M et al. Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America. Journal of Clinical Oncology. 2019;37(31):2875-2882. https://doi.org/10.1200/JCO.18.00141 DOI: https://doi.org/10.1200/JCO.18.00141
Gorodzinsky, F., Jetha, N., Leduc, D., Munk, P., Noonan, P. and Woods, S., 1998. Vision screening in infants and children. Paediatrics & Child Health, 3(4), pp.261-262. https://doi.org/10.1093/pch/3.4.261 DOI: https://doi.org/10.1093/pch/3.4.261
Loh A, Chiang M. Pediatric Vision Screening. Pediatrics in Review. 2018;39(5):225-234. https://doi.org/10.1542/pir.2016-0191 DOI: https://doi.org/10.1542/pir.2016-0191
Skalet A, Gombos D, Gallie B, Kim J, Shields C, Marr B et al. Screening Children at Risk for Retinoblastoma. Ophthalmology. 2018;125(3):453-458. https://doi.org/10.1016/j.ophtha.2017.09.001 DOI: https://doi.org/10.1016/j.ophtha.2017.09.001
Detección oportuna de alteraciones visuales en el recién nacido y lactante en el primer nivel de atención. México: Secretaría de Salud; 17 de marzo de 2016. [en línea] [citado el 03 de febrero 2021 Disponible en: http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/IMSS-793-16/ER.pdf
Diagnóstico y Manejo del Retinoblastoma. México: Consejo de Salubridad General [en línea]. [citado el 03 de febrero 2021]. Disponible en: http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/IMSS_270_13_RETINOBLASTOMA/270GRR.pdf
Protocolo Atención al menor de 5 años Vol.1 Honduras: Direción General de Normalización. [en línea]. Salud.gob.hn. [citado el 03 de febrero 2021] Disponible en: http://www.salud.gob.hn/site/index.php/normalizacion
Manual de Procedimiento para la Atención Integrada a las Enfermedades Prevalentes de la Infancia 0 a 5 años. Nicaragua: Normas Ministerio Salud [en línea]. [citado el 03 de febrero 2021 Disponible en: http://www.minsa.gob.ni/index.php/repository/Descargas-MINSA/Dirección-Generalde-Regulación-Sanitaria/Normas-Protocolos-yManuales/Normas-2018/
Caja Costarricense de Seguro Social | Publicaciones [en línea]. Costa Rica: [citado el 03 febrero 2021] Disponible en: https://www.ccss.sa.cr/publicaciones?pagina=9
Manual operativo para la evaluación de la agudeza visual en las niñas y niños de los CEN-CINAI. Manuales Operativos [en línea]. Costa Rica: Cencinai.go.cr. [citado en abril 2020]. Available from: https://www.cen-cinai.go.cr/index.php/proyectoseducativos/manuales-operativos
Guías para la atención integrada de niños y niñas, desde el nacimiento hasta los 9 años de edad. Panamá: Normas | Ministerio de Salud de la República de Panamá [en línea]. [citado el 03 febrero 2021]. Disponible en: http://www.minsa.gob.pa/normatividad/normas
National retinoblastoma strategy Canadian guidelines for care. Canadian Journal of Ophthalmology. 2009;44:S9-S47. https://doi.org/10.3129/i09-194 DOI: https://doi.org/10.3129/i09-194
Donahue S, Baker C. Procedures for the Evaluation of the Visual System by Pediatricians. Pediatrics. 2015;137(1):e20153597.
Munson M, Plewman D, Baumer K, Henning R, Zahler C, Kietzman A et al. Autonomous early detection of eye disease in childhood photographs. Science Advances. 2019;5(10):eaax6363. https://doi.org/10.1126/sciadv.aax6363 DOI: https://doi.org/10.1126/sciadv.aax6363
One Retinoblastoma World Map [en línea]. One Retinoblastoma World Map. [citado el 9 Septiembre 2020]. Disponible en: http://map.1rbw.org
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 José Rafael Ocampo Márquez, María José López Cruz, María José Marroquín Sarti
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
